re RNS and present NAV30 Apr 2020 13:00
The RNS is reassuring regarding the NAV. Obviously difficulty in calculating this accurately but it looks like they have worked diligently to offer the best available. Much of the portfolio is in the US and is in IT, and healthcare sectors that have not been heavily affected.
Historically the NAV has followed the tech 100 index reasonably well, and that and the S+P have rallied well from March 31st NAV calculation date, in the order of 12-14%.
The exchange rate to dollar and euro is essentially the same.
The NAV should be nearer to 3150 and on todays SP that gives a discount of over 37%.
I do worry that the recent rise was not some insider knowledge. But it still looks like a "screaming buy".